We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Presents Innovative Reagents and Instruments at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022

Vedalab (Cerisé, France) is presenting its innovative range of reagents and instruments at this year's MEDICA, the world's largest annual medical technology trade fair, which is taking place from 14-17 November in Düsseldorf, Germany. More...

Visitors to Vedalab’s booth at MEDICA 2022 can experience EASY READER+, a POC immunoassay analyzer that allows quantitative measurements from fingerprick whole blood samples using rapid lateral flow tests. Vedalab is showcasing a range of quantitative rapid tests for EASY READER+, such as the D-Dimer immunochromatographic rapid test for the quantitative detection of D-DIMER in whole blood or plasma, alongside the CRP (laboratory version) immunochromatographic rapid test for the quantitative detection of C-reactive protein in whole blood, serum or plasma.

Among the qualitative rapid tests for EASY READER+ being showcased at the event by Vedalab are the Combo Influenza A+B immunochromatographic rapid test for the qualitative detection of influenza type A and B virus from nasal or throat swab, nasal aspirate and nasopharyngeal washes; and the RSV immunochromatographic rapid test for the qualitative detection of RSV (respiratory syncytial virus) in the respiratory tract.

Related Links:
Vedalab 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Repetitive Pipette
VWR® Stepper Pro
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The AidaBREAST assay integrates multimodal data to provide patient-specific 10-year recurrence risk and individualized predictions of radiation therapy benefit (photo courtesy of PreludeDx)

Multi-Omic Assay Predicts Recurrence and Radiation Benefit in Early Breast Cancer

Early-stage invasive breast cancer is frequently managed with breast-conserving surgery followed by adjuvant radiation therapy, but the magnitude of benefit from radiation varies among patients.... Read more

Pathology

view channel
Image: The researchers derived a gene-based signature and a blood test to help identify this high-risk subgroup (photo credit: Shutterstock)

New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease

Diabetic kidney disease is a leading cause of chronic kidney disease and end-stage kidney disease, affecting 20%–40% of people with diabetes and more than 107 million individuals worldwide as of 2021.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.